WEBINAR
FEBRUARY 29, 2024
1:00 PM — 2:00 PM
Join Foley Hoag attorneys Donald Ware and Andrew London for this insightful program that will address:
- The history of the Bayh-Dole Act and its record of success in stimulating university innovations and economic growth
- An overview of the government's march-in rights on patents under Bayh-Dole, and how march-in rights were designed to further Bayh-Dole's purpose of promoting private investment in innovative technologies developed by non-profits
- A review of past march-in petitions, including NIH's consistent refusal to march-in based on licensee drug pricing practices
- The Biden Administration's Draft Framework for Considering the Exercise of March-In Rights and other ongoing attempts to use the government's march-in rights as leverage to regulate drug pricing
- What can we expect going forward? The future of the Bayh-Dole
Act and its impact on technology transfer, including:
- Licensee risk
- Investment in university-owned IP
- Industry and other partnerships
- License agreement terms
- Drug development
- U.S. competitiveness
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.